Feeling sick?

Use the Symptom Checker to check your symptoms

Add this to your profile
Banner for leaf pages 2

Insulin Glargine (Lantus)

Also known as Lantus

Insulin glargine, marketed by Sanofi-Aventis under the name Lantus, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert). Pharmacokinetically, it resembles basal insulin secretion of non-diabetic pancreatic beta cells. Sometimes, in type 2 diabetes and in combination with a short acting sulfonylurea (drugs which stimulate the pancreas to make more insulin), it can offer moderate control of serum glucose levels. In the absence of endogenous insulin—type 1 diabetes, depleted type 2 (in some cases) or latent autoimmune diabetes of adults in late stage—insulin glargine needs the support of fast acting insulin taken with food to reduce the effect of prandially derived glucose.

Source: Wikipedia

Estimated Total Cost: $154.64 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed insulin glargine to treat diabetes, diabetic peripheral neuropathy, diabetic retinopathy, and diabetic kidney disease.

Ajax-loader Loading...